Risk/benefit profile of panitumumab-based therapy in patients with metastatic colorectal cancer: evidence from five randomized controlled trials
Crossref DOI link: https://doi.org/10.1007/s13277-014-2354-6
Published Online: 2014-07-23
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tang, Na-Ping
Li, Hua
Qiu, Yun-Liang
Zhou, Guo-Min
Wang, Yan
Ma, Jing
Chang, Yan
Mei, Qi-Bing
Text and Data Mining valid from 2014-07-23